TG Therapeutics TGTX has announced positive top-line data from the late-stage ENHANCE study, which evaluated a consolidated ...

A major international phase III clinical trial, led by Queen Mary University of London, has found that ocrelizumab – a ...

Enrollment has reached 50% in an ongoing study testing whether a PET tracer can reliably measure myelin damage in people with ...

Researchers identified key differences between two widely used multiple sclerosis models, showing how each can better study myelin damage, immune responses, and repair. The findings may improve ...

Many women with multiple sclerosis (MS) have misconceptions about how the disease may affect pregnancy and childbirth, a ...

Two novel sub-types of multiple sclerosis (MS) have been identified, a discovery potentially paving the way for new treatments. Researchers employed artificial intelligence (AI) to assess brain scans ...

The gut microbiome comprises the trillions of bacteria and other microorganisms that live in our digestive tracts, and it has been increasingly connected to human health and disease. A new Yale study ...

In people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before disability worsened between people taking certain medications and those not ...

BUFFALO, N.Y. — A University at Buffalo research program that is investigating what causes some people with multiple sclerosis to experience severe and aggressive disease is beginning to shed light on ...

More than 1 million people across the United States live with multiple sclerosis (MS), a disease that affects the brain, ...

A 2-sample Mendelian randomization study found a potential connection between dietary intake and multiple sclerosis (MS) risk and severity. According to the National Multiple Sclerosis Society, diet ...